Vise Technologies, Inc. Ptc Therapeutics, Inc. Transaction History
Vise Technologies, Inc.
- $1.17 Billion
- Q4 2024
A detailed history of Vise Technologies, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Vise Technologies, Inc. holds 10,215 shares of PTCT stock, worth $529,852. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,215
Previous 10,887
6.17%
Holding current value
$529,852
Previous $403,000
14.39%
% of portfolio
0.04%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding PTCT
# of Institutions
284Shares Held
78.5MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$446 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$403 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$388 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$282 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$281 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.71B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...